N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2

Journal of Medicinal Chemistry
Ian R HardcastleHayley J Whitfield

Abstract

The adenosine 5'-triphosphate (ATP) competitive cyclin-dependent kinase inhibitor O(6)-cyclohexylmethylguanine (NU2058, 1) has been employed as the lead in a structure-based drug discovery program resulting in the discovery of the potent CDK1 and -2 inhibitor NU6102 (3, IC(50) = 9.5 nM and 5.4 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively). The SAR for this series have been explored further by the synthesis and evaluation of 45 N(2)-substituted analogues of NU2058. These studies have confirmed the requirement for the hydrogen bonding N(2)-NH group and the requirement for an aromatic N(2)-substituent to confer potency in the series. Additional potency is conferred by the presence of a group capable of donating a hydrogen bond at the 4'-position, for example, the 4'-hydroxy derivative (25, IC(50) = 94 nM and 69 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively), 4'-monomethylsulfonamide derivative (28, IC(50) = 9 nM and 7.0 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively), and 4'-carboxamide derivative (34, IC(50) = 67 nM and 64 nM vs CDK1/cyclinB and CDK2/cyclinA3, respectively). X-ray crystal structures have been obtained for key compounds and have been used to explain the observed trends in activity.

References

Jan 1, 1992·Annual Review of Biochemistry·C Norbury, P Nurse
Mar 9, 1995·Nature·D O Morgan
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·W F De AzevedoS H Kim
Feb 17, 1999·Bioorganic & Medicinal Chemistry Letters·P ImbachJ Zimmermann
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Sep 7, 2000·Biochemical and Biophysical Research Communications·R SoniB Chaudhuri
Dec 2, 2000·Journal of Medicinal Chemistry·M BarvianE Zhang
Mar 22, 2001·Journal of the National Cancer Institute·R SoniB Chaudhuri
Jan 25, 2002·Annual Review of Pharmacology and Toxicology·Ian R HardcastleRoger J Griffin
Apr 3, 2002·Trends in Molecular Medicine·Edward A Sausville
Apr 19, 2002·Journal of Medicinal Chemistry·Joseph SchoepferPascal Furet
May 2, 2002·Bioorganic & Medicinal Chemistry·Miguel A OrtegaAntonio Monge
Jul 23, 2002·Current Opinion in Chemical Biology·Peter L Toogood
Jul 26, 2002·Journal of Medicinal Chemistry·Ashleigh E GibsonHayley J Whitfield
Sep 19, 2002·Trends in Pharmacological Sciences·Marie KnockaertLaurent Meijer
Sep 24, 2002·Nature Structural Biology·Thomas G DaviesHayley J Whitfield
Dec 17, 2002·Bioorganic & Medicinal Chemistry Letters·Veronique MesguicheIan R Hardcastle
Mar 12, 2003·Trends in Pharmacological Sciences·Zoe A StewartJennifer A Pietenpol
Mar 28, 2003·Bioorganic & Medicinal Chemistry·Apos DermatakisWanda DePinto
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4

❮ Previous
Next ❯

Citations

Nov 12, 2013·Journal of Computer-aided Molecular Design·Rocco VarelaAjay N Jain
Mar 23, 2012·Chemical Reviews·Alexander DömlingKan Wang
Apr 6, 2006·The AAPS Journal·Jayalakshmi SridharNagarajan Pattabiraman
Sep 8, 2012·Journal of Cell Science·Suzanna L ProsserAndrew M Fry
Oct 1, 2014·BMC Bioinformatics·William R PittTom L Blundell
Jan 7, 2014·Expert Opinion on Investigational Drugs·Mathew C CasimiroRichard G Pestell
Nov 20, 2015·Journal of Chemical Theory and Computation·Edward HarderRichard A Friesner
Sep 3, 2013·European Journal of Medicinal Chemistry·Donatella BoschiAlberto Gasco
Nov 20, 2014·Journal of Computer-aided Molecular Design·Daniel CappelJianxin Duan
Sep 1, 2015·Chemistry & Biology·Elizabeth AnscombeRoger J Griffin
Dec 21, 2016·Journal of Chemical Theory and Computation·Agastya P BhatiPeter V Coveney
Dec 4, 2009·European Journal of Medicinal Chemistry·Lena KoehlerFrank Wuest
Mar 1, 2006·Bioorganic & Medicinal Chemistry·Michel Legraverend, David S Grierson
Apr 1, 2014·European Journal of Medicinal Chemistry·Mariusz MojzychVladimír Kryštof
Feb 17, 2018·Chemistry : a European Journal·Nilesh R Kamble, Snorri Th Sigurdsson
Apr 22, 2016·Organic & Biomolecular Chemistry·Dong-Chao WangHai-Ming Guo
May 8, 2010·Organic & Biomolecular Chemistry·Francesco MarchettiIan R Hardcastle
Nov 12, 2016·Oncotarget·Christopher R CoxonCéline Cano
Jan 2, 2018·Oncotarget·James BogenbergerRaoul Tibes
Sep 10, 2019·Journal of Biomolecular Structure & Dynamics·Stefano GuglielmoRoberta Fruttero
Feb 6, 2013·Organic & Biomolecular Chemistry·Honorine LebraudBernard T Golding
Apr 4, 2019·Journal of Cheminformatics·Willem JespersHugo Gutiérrez-de-Terán
Jan 26, 2021·Journal of Chemical Theory and Computation·Mateusz K BieniekPeter V Coveney
Aug 21, 2007·Journal of Combinatorial Chemistry·Chao CheZhen Yang
Mar 29, 2007·The Journal of Physical Chemistry. B·Jans H Alzate-MoralesRenato Contreras
May 6, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Suman Kumar Mandal, Parthapratim Munshi
Jan 24, 2008·Journal of Chemical Information and Modeling·Steffen RennerFabian Mörchen
Nov 18, 2005·Bioorganic & Medicinal Chemistry·Nicolas FoloppeAndrew Potter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.